Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Schibli

Showing results (171-180 of 301) with videos related to

Pageof 31
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2022
Preclinical investigations using [<sup>177</sup>Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancerViviane J Tschan, Francesca Borgna, Sarah D Busslinger, et al.
Molecular Pharmaceutics|February 22, 2017
Radiolabeled <sup>111</sup>In-FGF-2 Is Suitable for In Vitro/Ex Vivo Evaluations and In Vivo ImagingAlessandra Moscaroli, Gabriel Jones, Tessa Lühmann, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2014
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 ReceptorLinjing Mu, Roger Slavik, Adrienne Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Validation of Folate Receptor-α Selectivity of 6<i>S</i>-5-Methyltetrahydrofolate-Based Radioconjugates: A Prerequisite for Therapeutic Application?Ana Katrina Mapanao, Benjamin D Hunkeler, Giovanni Marzaro, et al.
International Journal of Cancer|July 29, 2011
L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancerEliane Fischer, Jürgen Grünberg, Susan Cohrs, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 4, 2012
Identification, characterization and suppression of side-products formed during the synthesis of high dose ⁶⁸Ga-DOTA-TATELinjing Mu, Rolf Hesselmann, Ufuk Oezdemir, et al.
Frontiers in Neuroscience|August 12, 2016
Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET ImagingAchi Haider, Adrienne Müller Herde, Roger Slavik, et al.
Cancers|September 9, 2023
Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate RadioconjugatesSarah D Busslinger, Anna E Becker, Christian Vaccarin, et al.
Bioconjugate Chemistry|January 1, 2013
Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targetingThomas Betzel, Cristina Müller, Viola Groehn, et al.
EJNMMI Radiopharmacy and Chemistry|March 23, 2018
<sup>44</sup>Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigationsKatharina A Domnanich, Cristina Müller, Renata Farkas, et al.
Pageof 31

Showing results (171-180 of 301) with videos related to

Sort By:
Pageof 31
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2022
Preclinical investigations using [<sup>177</sup>Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancerViviane J Tschan, Francesca Borgna, Sarah D Busslinger, et al.
Molecular Pharmaceutics|February 22, 2017
Radiolabeled <sup>111</sup>In-FGF-2 Is Suitable for In Vitro/Ex Vivo Evaluations and In Vivo ImagingAlessandra Moscaroli, Gabriel Jones, Tessa Lühmann, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2014
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 ReceptorLinjing Mu, Roger Slavik, Adrienne Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Validation of Folate Receptor-α Selectivity of 6<i>S</i>-5-Methyltetrahydrofolate-Based Radioconjugates: A Prerequisite for Therapeutic Application?Ana Katrina Mapanao, Benjamin D Hunkeler, Giovanni Marzaro, et al.
International Journal of Cancer|July 29, 2011
L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancerEliane Fischer, Jürgen Grünberg, Susan Cohrs, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 4, 2012
Identification, characterization and suppression of side-products formed during the synthesis of high dose ⁶⁸Ga-DOTA-TATELinjing Mu, Rolf Hesselmann, Ufuk Oezdemir, et al.
Frontiers in Neuroscience|August 12, 2016
Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET ImagingAchi Haider, Adrienne Müller Herde, Roger Slavik, et al.
Cancers|September 9, 2023
Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate RadioconjugatesSarah D Busslinger, Anna E Becker, Christian Vaccarin, et al.
Bioconjugate Chemistry|January 1, 2013
Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targetingThomas Betzel, Cristina Müller, Viola Groehn, et al.
EJNMMI Radiopharmacy and Chemistry|March 23, 2018
<sup>44</sup>Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigationsKatharina A Domnanich, Cristina Müller, Renata Farkas, et al.
Pageof 31